ASXL1 and acquired polycythemia vera: In our PV patients, ASXL1 mutations were associated with a decreased OS, but this effect was mainly driven by their association with other “high-risk” mutations since patients with isolated ASXL1 mutation did not have decreased overall or transformation-free survival.